Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Jacques Col"'
Autor:
Richard C. Becker, Harvey D. White, Shaun G. Goodman, Elliott M. Antman, John Ducas, Richard L. Gallo, James J. Ferguson, Glenn N. Levine, Kenneth W. Mahaffey, Jacques Col, Robert M. Califf, Anatoly Langer, Sarah A. Spinler, Philip E. Aylward, Simon T. Tonev
Publikováno v:
International Journal of Cardiology. 139:123-133
Background: Obese patients are at increased risk of acute coronary syndromes (ACS). We evaluated the prevalence of obesity in a large ACS population, as well as the relationship between body mass index (BMI) and the use of cardiac medications and pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf5b3d226d36ec0563ca87c9ed51817
https://doi.org/10.1016/j.ijcard.2008.10.008
https://doi.org/10.1016/j.ijcard.2008.10.008
Autor:
Judith S. Hochman, John K. French, Vladimir Dzavik, S. Chiu Wong, Jacques Col, Shannon M. Harkness, Lynn A. Sleeper, Harvey D. White
Publikováno v:
The American Journal of Cardiology. 104:24-28
Myocardial infarction often develops when thrombosis occurs at lesions that have not previously been flow limiting. However, the development of cardiogenic shock complicating acute myocardial infarction in such circumstances has received little atten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd3ccb829ae8c423b3e7e6e7fa295c9e
https://doi.org/10.1016/j.amjcard.2009.03.002
https://doi.org/10.1016/j.amjcard.2009.03.002
Autor:
Shaun G. Goodman, James W. Hoekstra, Charles V. Pollack, Robert M. Califf, Jacques Col, Kenneth W. Mahaffey, James J. Ferguson, Marc Cohen, Elliott M. Antman, Anatoly Langer, Harvey D. White, Karen S. Pieper
Publikováno v:
Journal of the American College of Cardiology. 48:1346-1354
OBJECTIVES The purpose of this study was to compare the effect of receiving pretreatment with antithrombin before randomization as well as overall efficacy and safety of enoxaparin versus unfractionated heparin (UFH) in the SYNERGY (Superior Yield of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e10a372295fc5fe2b3443ee493d96179
https://doi.org/10.1016/j.jacc.2006.05.058
https://doi.org/10.1016/j.jacc.2006.05.058
Autor:
SHAMIR R. MEHTA, M. D, M. SC, CHRISTOPHER B. GRANGER, WILLIAM E. BODEN, PHILIPPE GABRIEL STEG, JEAN PIERRE BASSAND, DAVID P. FAXON, RIZWAN AFZAL, SUSAN CHROLAVICIUS, R. N, SANJIT S. JOLLY, PETR WIDIMSKY, ALVARO AVEZUM, HANS JURGEN RUPPRECHT, JUN ZHU, JACQUES COL, MADHU K. NATARAJAN, CRAIG HORSMAN, B. SC, KEITH A. A. FOX, M. B, C.H. B, AND SALIM YUSUF, M. B, B. S, D. PHIL, PIZZOLATO, GILBERTO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01099::7ccf32a8560aad1ef99f00d950e4fdb3
https://hdl.handle.net/11368/2288197
https://hdl.handle.net/11368/2288197
Publikováno v:
European Heart Journal Supplements. 3:J24-J31
Options for antiplatelet therapy have increased in the last decade, with thienopyridines and GP IIb/IIIa receptor antagonists joining aspirin on the roster of available antiplatelet agents. Both North American (ACC/AHA) and European (ESC) cardiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d1feff4a2af9e23327934ae67177f24
https://doi.org/10.1016/s1520-765x(01)90137-3
https://doi.org/10.1016/s1520-765x(01)90137-3
Autor:
Robert M. Califf, Venu Menon, Judith S. Hochman, Eric R. Bates, M Pfisterer, David R. Holmes, R.D. Anderson, Eric J. Topol, David Hasdai, Erik Magnus Ohman, Jacques Col, A. Stebbins
Publikováno v:
European Heart Journal. 21:1928-1936
Aims: We used the GUSTO-I and GUSTO-III databases to evaluate our performance in treating cardiogenic shock patients over much of the 1990s. Methods and Results: GUSTO-I (1990-1993) and GUSTO-III (1995-1997) prospectively identified all patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abffc0ad115853265d03f2630503f51
https://doi.org/10.1053/euhj.2000.2240
https://doi.org/10.1053/euhj.2000.2240
Publikováno v:
Fibrinolysis and Proteolysis. 14:351-357
A new bedside lytic assay using dry reagent technology for rapid (3-5 min) detection of streptokinase resistance (SKR) was recently introduced, which measures lysis onset time (LOT) of whole blood clot in response to high and low streptokinase (SK) c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fec5092bb9ab79422934bcc982c1758b
https://doi.org/10.1054/fipr.2000.0094
https://doi.org/10.1054/fipr.2000.0094
Autor:
Judith S. Hochman, James Slater, Jean Boland, Cliff P. Connery, Tracy A Antonelli, Venu Menon, Vladimir Dzavik, Jacques Col, Mark Menegus, Mark A. Greenberg, Robert J Brown
Publikováno v:
Journal of the American College of Cardiology. 36:1117-1122
OBJECTIVES We sought to compare the characteristics and outcomes of patients with acute myocardial infarction (MI) and cardiogenic shock (CS) caused by rupture of the ventricular free wall or tamponade versus shock from other causes. BACKGROUND Free-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff75b79fd95587b565d30f4be4a14af
https://doi.org/10.1016/s0735-1097(00)00845-7
https://doi.org/10.1016/s0735-1097(00)00845-7
Autor:
Jean-P Santoni, Rudy Scheldewaert, Ian R. Starkey, Michel E. Bertrand, William E. Boden, Wiek H. van Gilst, Anne Whitehead, K.I. Lie, Ole Lederballe Pedersen, Jacques Col, Desmond G. Julian, Marc Carlier, Kim Fox
Publikováno v:
Scopus-Elsevier
LANCET, 355(9217), 1751-1756. ELSEVIER SCIENCE INC
LANCET, 355(9217), 1751-1756. ELSEVIER SCIENCE INC
Background Diltiazem reduces non-fatal reinfarction and refractory ischaemia after non-Q-wave myocardial infarction, an acute coronary syndrome similar to the incomplete infarction that occurs after successful reperfusion. We postulated that this age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbf4c3ef17bccaa07fcdb6bacc420d4
https://doi.org/10.1016/s0140-6736(00)02262-5
https://doi.org/10.1016/s0140-6736(00)02262-5
Autor:
Judith S. Hochman, Lynn A. Sleeper, John G. Webb, Timothy A. Sanborn, Harvey D. White, J. David Talley, Christopher E. Buller, Alice K. Jacobs, James N. Slater, Jacques Col, Sonja M. McKinlay, Michael H. Picard, Mark A. Menegus, Jean Boland, Vladimir Dzavik, Christopher R. Thompson, S. Chiu Wong, Richard Steingart, Robert Forman, Philip E. Aylward, Emilie Godfrey, Patrice Desvigne-Nickens, Thierry H. LeJemtel
Publikováno v:
New England Journal of Medicine. 341:625-634
Background The leading cause of death in patients hospitalized for acute myocardial infarction is cardiogenic shock. We conducted a randomized trial to evaluate early revascularization in patients with cardiogenic shock. Methods Patients with shock d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfe2f02258cc6401b7ba608e555d5770
https://doi.org/10.1056/nejm199908263410901
https://doi.org/10.1056/nejm199908263410901